Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876377 · ClinicalTrials.gov registry record
Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
A clinical trial of COVID-19 and SARS-CoV-2, sponsored by Pfizer.
- Active
- Registry status
- 1
- Enrollment target
- 1
- Study location
NCT05876377 is a study of COVID-19 and SARS-CoV-2 that is active but no longer recruiting, run by Pfizer. The registered enrollment target is 1 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05876377, a study of COVID-19 and SARS-CoV-2, is active but no longer recruiting, sponsored by Pfizer.
- ACTIVE NOT RECRUITING
- Registry status
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to use vaccination information from state vaccine registries linked with HealthVerity insurance claims for the following: * to measure how effective the Pfizer-BioNTech vaccine is at preventing post-COVID conditions. * to understand characteristics of patients who are receiving COVID-19 vaccines. All patients whose information is kept unidentified in the HealthVerity database are eligible to be included for both aims of this study.
Conditions Studied
Interventions
- BIOLOGICAL Pfizer-BioNTech COVID-19 mRNA vaccine
Study Locations (1)
New York
- Pfizer - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-10-23 |
| Est. Completion | 2026-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05876377
The ClinicalTrials.gov registry entry for NCT05876377 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Pfizer-BioNTech COVID-19 mRNA vaccine is the first listed.
NCT05876377 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05876377 about?
NCT05876377 is a clinical study titled "Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data". This study aims to use vaccination information from state vaccine registries linked with HealthVerity insurance claims for the following: * to measure how effective the Pfizer-BioNTech vaccine is at preventing post-COVID conditions. * to understand characteristics of patients who are receiving COVI...
What is the current status of trial NCT05876377?
This trial is currently active not recruiting. The enrollment target is 1 participants. The study started on 2023-10-23. Estimated completion is 2026-09-30.
What conditions does trial NCT05876377 study?
This clinical trial studies the following conditions: COVID-19, SARS-CoV-2, Post-Acute COVID-19 Syndrome.
What interventions are being tested in trial NCT05876377?
The interventions under investigation include: Pfizer-BioNTech COVID-19 mRNA vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05876377?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05876377 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.